Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?
Joseph Raffaele, Physician-Scientist in Longevity Medicine, CEO of PhysioAge LLC, shared a post on LinkedIn about a recent article by Dominic Denk et al, published in Nature Aging:
”Mitochondria shape immune function over decades.
A recent human trial asked whether we could change this fate.
If we improve mitochondrial quality inside immune cells, can we alter immune aging markers in people?
As immune cells age, mitochondrial dysfunction accumulates.
Damaged mitochondria persist due to impaired mitophagy (damaged mitochondria cleanup).
Energy production declines, reactive oxygen species increase, and immune cells drift toward exhaustion and chronic inflammatory signaling.
In this study, 50 healthy middle-aged adults received 𝟏,𝟎𝟎𝟎 𝐦𝐠/𝐝𝐚𝐲 𝐨𝐟 𝐮𝐫𝐨𝐥𝐢𝐭𝐡𝐢𝐧 𝐀 𝐟𝐨𝐫 𝐟𝐨𝐮𝐫 𝐰𝐞𝐞𝐤𝐬, a compound shown to induce mitophagy and improve mitochondrial quality control.
Primary endpoints focused on phenotypic and metabolic remodeling of peripheral immune cells, rather than nonspecific clinical outcomes.
Participants receiving urolithin A showed:
- An expansion of naïve-like CD8 T cells
- Improved immune cell metabolic flexibility
- Increased mitochondrial biogenesis in key immune populations
Importantly, inflammatory cytokines and immune function were evaluated alongside cellular metabolism, allowing investigators to directly link mitochondrial quality with immune behavior rather than treating them as separate phenomena.
What makes this study important is the template it provides.
Aging biology advances when trials target a known mechanism, measure the right cell populations, and use human-relevant endpoints. This is the kind of evidence that moves geroscience from theory toward clinical practice.”
Title: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Authors: Dominic Denk, Anurag Singh, Herbert G. Kasler, Davide D’Amico, Julia Rey, Lucía Alcober-Boquet, Johanna M. Gorol, Christoph Steup, Ritesh Tiwari, Ryan Kwok, Rafael J. Argüello, Julie Faitg, Kathrin Sprinzl, Stefan Zeuzem, Valentina Nekljudova, Sibylle Loibl, Eric Verdin, Chris Rinsch, Florian R. Greten
Read the Full Article on Nature Aging
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
-
Jul 19, 2026, 16:54Belén de la Morena Barrio: Presenting Our Research on Long-Read Sequencing for Genetic Diagnosis at ISTH 2026
-
Jul 19, 2026, 16:52Shamee Shastry: Sometimes the Answer is Not in the Test Tube Alone, but at the Patient’s Bedside
-
Jul 19, 2026, 16:52Manuela Albisetti: Congratulations to Alessandra Bosch on an Outstanding ISTH 2026 Talk
-
Jul 19, 2026, 16:44Fernanda Orsi: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:37William Aird: A Visual Guide to Understanding von Willebrand Disease